Introduction

American Journal of Cardiology

Volumn 98, Issue 7 SUPPL., 2006, Pages 1-4

  Sica, Domenic A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LISINOPRIL; METOPROLOL SUCCINATE;

BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CYTOKINE PRODUCTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG TOLERABILITY; EDITORIAL; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; IMMUNOMODULATION; INFUSION PUMP; INTRINSIC SYMPATHOMIMETIC ACTIVITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHARMACODYNAMICS; PRIORITY JOURNAL; REPERFUSION INJURY; STABLE ANGINA PECTORIS; SUSTAINED DRUG RELEASE;

EID: 33749124111     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.07.013     Document Type: Editorial

References (14)

1. Bristow M.R., Larrabee P., Muller-Beckmann B., Minobe W., Roden R., Skerl L., Klein J., Handwerger D., and Port J.D. Effects of carvedilol on adrenergic receptor pharmacology in human ventricular myocardium and lymphocytes. Clin Investig 70 suppl 1 (1992) S105-S113
2. Feuerstein G.Z., and Ruffolo Jr. R.R. Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection. Eur Heart J 16 suppl F (1995) 38-42
3. Nichols A.J., Gellai M., and Ruffolo Jr. R.R. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol. Fundam Clin Pharmacol 5 (1991) 25-38
4. Ruffolo R.R., and Feuerstein G.Z. Neurohormonal activation, oxygen free radicals, and apoptosis in the pathogenesis of congestive heart failure. J Cardiovasc Pharmacol 32 suppl 1 (1998) S22-S30
5. Yoshikawa T., Port J.D., Asano K., Chidiak P., Bouvier M., Dutcher D., Roden R.L., Minobe W., Tremmel K.D., and Bristow M.R. Cardiac adrenergic receptor effects of carvedilol. Eur Heart J 17 suppl B (1996) 8-16
6. Bristow M.R. Mechanism of action of beta-blocking agents in heart failure. Am J Cardiol 80 suppl (1997) 26L-40L
7. Dunn C.J., Lea A.P., and Wagstaff A.J. Carvedilol: a reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs 54 (1997) 161-185
8. CAPRICORN Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 357 (2001) 1385-1390
9. Brunvand H., Liu G., Ma X.L., Yue T.L., Ruffolo Jr. R.R., and Feuerstein G.Z. SB 211475, a metabolite of carvedilol, reduces infarct size after myocardial ischemic and reperfusion injury in rabbits. Eur J Pharmacol 356 (1998) 193-198
10. Lin H.C., Huang Y.T., Wei H.C., Yang Y.Y., Lee T.Y., Wang Y.W., Hou M.C., and Lee S.D. Hemodynamic effects of one week of carvedilol administration on cirrhotic rats. J Gastroenterol 41 (2006) 361-368
11. Afonso R.A., Patarrao R.S., Macedo M.P., and Carmo M.M. Carvedilol action is dependent on endogenous production of nitric oxide. Am J Hypertens 19 (2006) 419-425
12. Ohtsuka T., Hamada M., Hiasa G., Sasaki O., Suzuki M., Hara Y., Shigematsu Y., and Hiwada K. Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy. J Am Coll Cardiol 37 (2001) 412-417
13. Feuerstein G., Yue T.L., Ma X., and Ruffolo R.R. Novel mechanisms in the treatment of heart failure: inhibition of oxygen radicals and apoptosis by carvedilol. Prog Cardiovasc Dis 41 (1998) 17-24
14. Kindermann M., Maack C., Schaller S., Finkler N., Schmidt K.I., Laer S., Wuttke H., Schafers H.J., and Bohm M. Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo. Circulation 109 (2004) 3182-3190